Loading Events

Ocular Therapeutix In-Person/Virtual Investor Day 2024

Banners - 2024-06-05T092253.489
DATE: June 13, 2024

About The Event

Please join the Ocular Therapeutix management team for its 2024 Investor Day featuring prominent retinal disease Key Opinion Leaders (KOLs).

Ocular’s Investor Day will focus on providing:

  • An overview of the Company’s updated corporate strategy, pipeline priorities, and future development plans
  • A review of Ocular’s registration program for AXPAXLI™ in the treatment of wet age-related macular degeneration (wet AMD), including a progress update for the ongoing SOL-1 study
  • An update and discussion of the Phase 1 HELIOS data for AXPAXLI in non-proliferative diabetic retinopathy (NPDR)

The event will include KOL presentations and a roundtable discussion, followed by a live Q&A session.

In-person attendees are invited to join Ocular leadership and the participating KOLs for a networking reception to conclude the event.